Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)
Clinical trial NCT01795950 · TERMINATED
Trial details
- NCT number
- NCT01795950
- Sponsor
- United Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2015-12-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.